Видео ютуба по тегу Trial: Comfort-Ii

JAK Inhibitor Ruxolitinib COMFORT-II Trial Shows Positive Results
JAK Inhibitor Ruxolitinib COMFORT-II Trial Shows Positive Results
COMFORT-II clinical trial: the 5 yr results
COMFORT-II clinical trial: the 5 yr results
The 5-year update on the COMFORT-II clinical trial of ruxolitinib
The 5-year update on the COMFORT-II clinical trial of ruxolitinib
COMFORT II Discussion with Dr. Claire Harrison on the Side Effects of the Trial
COMFORT II Discussion with Dr. Claire Harrison on the Side Effects of the Trial
Overview of the COMFORT II trial and comparison to the COMFORT I trial results.
Overview of the COMFORT II trial and comparison to the COMFORT I trial results.
The COMFORT-I and COMFORT-II Trials in Myelofibrosis
The COMFORT-I and COMFORT-II Trials in Myelofibrosis
Overview of the COMFORT-II clinical trial results presented at ASH 2015
Overview of the COMFORT-II clinical trial results presented at ASH 2015
Update on JAK Inhibitor — COMFORT II Trial interview with Claire Harrison, MD, at ASH 2011
Update on JAK Inhibitor — COMFORT II Trial interview with Claire Harrison, MD, at ASH 2011
Walking with Jesus Daily Journey - Day 9
Walking with Jesus Daily Journey - Day 9
The impact of early ruxolitinib treatment on OS in the COMFORT-I and COMFORT-II studies
The impact of early ruxolitinib treatment on OS in the COMFORT-I and COMFORT-II studies
COMFORT II - Why is spleen volume so important? and other questions with Dr. Claire Harrison
COMFORT II - Why is spleen volume so important? and other questions with Dr. Claire Harrison
Dr. Cervantes Discusses COMFORT-II Long-Term Data
Dr. Cervantes Discusses COMFORT-II Long-Term Data
COMFORT II Additional Data Discussion with Dr. Claire Harrison
COMFORT II Additional Data Discussion with Dr. Claire Harrison
What do the results of the COMFORT I and II trial mean to patients? (Video 5 of 5).
What do the results of the COMFORT I and II trial mean to patients? (Video 5 of 5).
COMFORT Trials: Initiating Therapy for Myelofibrosis
COMFORT Trials: Initiating Therapy for Myelofibrosis
Dr. Ruben Mesa Discusses the COMFORT Ruxolitinib Trials
Dr. Ruben Mesa Discusses the COMFORT Ruxolitinib Trials
What's New from COMFORT II?
What's New from COMFORT II?
Dr. Mesa on the Long-Term Experience from the COMFORT Trials
Dr. Mesa on the Long-Term Experience from the COMFORT Trials
Analyses from COMFORT trials of ruxolitinib for myelofibrosis
Analyses from COMFORT trials of ruxolitinib for myelofibrosis
Dr. John Mascarenhas on the COMFORT-I/II Studies for Ruxolitinib in Myelofibrosis
Dr. John Mascarenhas on the COMFORT-I/II Studies for Ruxolitinib in Myelofibrosis